Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Vanguard Information Technology Index Fund ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while Vanguard Information Technology Index Fund ETF trades at $128.74 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 74.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | VGT | |
|---|---|---|
Market Cap | $2.28B | $170.20B |
Volume | 3,128,960 | 3,243,213 |
Sector | Health | — |
52-Week High | $15.46 | $129.79 |
52-Week Low | $1.39 | $83.59 |
Enterprise Value | $2.15B | — |
Typical Hold Time | — | 129 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VGT trades at $129.37, down 0.32% on the day, with technical indicators showing a bullish trend supported by moving averages but overbought RSI levels. The ETF recently hit a new 52-week high, reflecting strong momentum in the technology sector. Recent news highlights VGT's historical performance, with articles emphasizing its low expense ratio and concentration in tech giants like Nvidia, Apple, and Microsoft.
The outlook remains positive given the ETF's exposure to leading technology companies and strong historical returns, though risks include sector concentration and potential AI slowdown. Analyst sentiment is generally bullish, with institutional buying activity supporting confidence in continued growth despite valuation concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
